MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, RVMDW had -$324,462K decrease in cash & cash equivalents over the period. -$637,568K in free cash flow.

Cash Flow Overview

Change in Cash
-$324,462K
Free Cash flow
-$637,568K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
Net loss
-766,409
Loss on disposal of fixed assets
-32
Amortization of intangible assets
801
Stock-based compensation expense
84,693
Depreciation and amortization
5,513
Change in fair value of warrant liabilities and contingent earn-out shares
2,731
Non-cash interest expense on liability related to sale of future royalties
12,294
Net amortization of premium or discount on marketable securities
23,277
Amortization of operating lease right-of-use asset
5,542
Impairment of assets
0
Accounts receivable
0
Prepaid expenses and other current assets
6,290
Accounts payable
20,036
Accrued expenses and other current liabilities
57,663
Operating lease liability
-1,198
Long-term deposits
4,723
Other noncurrent assets
12,718
Other noncurrent liabilities
1,807
Net cash used in operating activities
-623,503
Purchases of marketable securities
1,498,365
Maturities of marketable securities
1,549,222
Sales of marketable securities
6,384
Purchases of property and equipment
14,065
Net cash provided by (used in) investing activities
43,176
Proceeds from issuance of common stock upon at-the-market offering, net of issuance costs
0
Proceeds from issuance of common stock under equity incentive plans
6,973
Proceeds from issuance of common stock related to employee stock purchase plan
4,644
Proceeds from the sale of future royalties
244,215
Exercise of warrants
4
Deferred offering costs
-29
Net cash provided by financing activities
255,865
Net decrease in cash, cash equivalents and restricted cash
-324,462
Cash and cash equivalents at beginning of period
546,762
Cash and cash equivalents at end of period
222,300
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Revolution Medicines, Inc. (RVMDW)

Revolution Medicines, Inc. (RVMDW)